The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 17095 | 14.07.2022
Good laboratory practice (GLP) is a quality system concerned with the organisational process and the conditions under wh...
ID 16728 | 27.05.2022 / In allegato Nota e modello
Nota Ministero della Salute del 26 maggio 2022 - Modello di etichetta dei pro...
ID 15174 | 15.12.2021 / In allegato Linee guida 2021
Il Dipartimento della Protezione Civile ha diramato, ai sensi dell...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
